RPR4 - Overview: Respiratory Profile, Region 4, Sub-tropic Florida (Florida S. of Orlando), Serum
Assessing sensitization to various inhalant allergens commonly found in sub-tropic Florida, which is south of Orlando Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic...
RPR15 - Overview: Respiratory Profile, Region 15, Intermountain West (Southern ID, NV), Serum
Assessing sensitization to various inhalant allergens commonly found in the Intermountain West region including southern Idaho and Nevada Defining the allergen responsible for eliciting signs and symptoms Identifying...
RPR19 - Overview: Respiratory Profile, Region 19, Puerto Rico, Serum
Assessing sensitization to various inhalant allergens commonly found in Puerto Rico Defining the allergen responsible for eliciting signs and symptoms Identifying allergens: -Responsible for allergic response and/or anaphylactic...
RPR10 - Overview: Respiratory Profile, Region 10, Southwestern Grasslands (OK, TX), Serum
Assessing sensitization to various inhalant allergens commonly found in the Southwestern Grasslands region, including Oklahoma and Texas Defining the allergen responsible for eliciting signs and symptoms Identifying...
RFPN - Overview: Rheumatoid Factor Panel, Serum
Evaluating patients at-risk of rheumatoid arthritis (RA) or features of inflammatory arthritis Differentiating the antibody isotype profile in patients positive for rheumatoid factor (RF) Aid in the risk stratification of RF-seropositive...
Assessing sensitization to various inhalant allergens commonly found in the Rocky Mountain region including Arizona, Colorado, Idaho, New Mexico, Utah, and Wyoming Defining the allergen responsible for eliciting signs and symptoms...
RPR9 - Overview: Respiratory Profile, Region 9, Great Plains (KS, ND, NE, SD), Serum
Assessing sensitization to various inhalant allergens commonly found in the Great Plains region including Kansas, North Dakota, Nebraska, and South Dakota Defining the allergen responsible for eliciting signs and symptoms Identifying...
RPR8 - Overview: Respiratory Profile, Region 8, Central Midwest (IA, IL, MO), Serum
Assessing sensitization to various inhalant allergens commonly found in the Central Midwest region including Iowa, Illinois, and Missouri Defining the allergen responsible for eliciting signs and symptoms Identifying...
RPR7 - Overview: Respiratory Profile, Region 7, Northern Midwest (MI, MN, WI), Serum
Assessing sensitization to various inhalant allergens commonly found in the Northern Midwest region including Michigan, Minnesota, and Wisconsin Defining the allergen responsible for eliciting signs and symptoms Identifying...
RPR6 - Overview: Respiratory Profile, Region 6, South Central (AL, AR, LA, MS), Serum
Assessing sensitization to various inhalant allergens commonly found in the South Central region including Alabama, Arkansas, Louisiana and Mississippi Defining the allergen responsible for eliciting signs and symptoms Identifying...
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...